Copart heads into the back half of July with a fresh analyst cut, a stock trading near year-to-date lows, and short sellers who have quietly rebuilt positions over the past month.
The standout this week is on the Street. Barclays' John Babcock lowered his price target to $26 from $32 this morning, while keeping an Underweight rating — the only change from a bellwether firm in the past two weeks. That $26 target now sits below the current price of $27.17, making it the most bearish published target among active analysts. The broader analyst picture is divided. Baird holds an Outperform with a $48 target, and Freedom Broker initiated in late June with a Buy at $39. The consensus mean is $40.30 — nearly 50% above where the stock is trading — but that average is skewed by bulls who have not revisited their numbers since the stock dropped 10% in a month. The Barclays cut is a signal that at least part of the Street is marking targets down toward where the stock actually lives. Analyst recommendation divergence is in the 98th percentile of the ORTEX universe, meaning the bull-bear split is wider than almost any comparable name — that kind of disagreement rarely resolves quietly.
The lending market tells a different story: this is not a heavily shorted stock. Short interest is running at 3.95% of the free float, up about 11.5% over the past 30 days as positions were added through late June and early July. That month-long build is worth noting, even if the absolute level remains modest. Borrowing costs have moved with it — cost to borrow jumped 23% on the week to 0.60%, and is up roughly 49% over the past month. That said, 0.60% remains firmly in "low" territory. Availability is completely unconstrained, with hundreds of millions of shares available in the lending pool. There is no squeeze pressure here. Options positioning is mildly cautious — the put/call ratio is 0.66, a touch above its 20-day average of 0.55, but less than one standard deviation from the mean. Nothing in the borrow or options market suggests aggressive directional pressure.
The valuation picture has compressed significantly. The price-to-earnings multiple has contracted by roughly 1.5 points over the past 30 days, now at 16.6x. Price-to-book has dropped by about a quarter of a point over the same window to 2.5x. EV/EBITDA is at 10.4x and drifting lower. For a business with Copart's network advantages — the bull case rests on a 5.6% rise in average selling prices and international buyers now representing 38% of auction units — these are not demanding multiples. The bear case centres on depressed unit growth and a 1% drop in gross transaction value per lot in the auction business, raising questions about whether pricing strength can persist without volume support.
Insider activity adds a layer of context. A board-linked investment manager sold 80,000 shares at $27.55 on July 13. CEO Jeff Liaw has sold stock at regular intervals — at $40, $33, and $44 across the past year — all as the stock has drifted lower. Net insider selling over the past 90 days totals around $3.1 million. None of these sales look panicked, but there has been no buying at current levels from anyone close to the business. The EPS surprise factor score of 71 is reasonable, and the company has generally beaten estimates — the last print in May saw the stock move up 2.3% the following day. The next earnings event is September 3.
Peer correlation is loose, but the week's moves are instructive. ACVA, an adjacent vehicle auction platform, gained 9.7% on the week and 7% on Tuesday alone. RBA — Ritchie Bros., with direct auction-market overlap — added 1.3% on the week. Copart fell 1.3%. That divergence against ACVA in particular is worth watching as September earnings approach, given both companies operate in the same vehicle remarketing ecosystem.
The next clear focal point is the September 3 earnings call, where the debate between Baird's $48 bull case and Barclays' fresh $26 target gets its first hard data since May.
See the live data behind this article on ORTEX.
Open CPRT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
